138 related articles for article (PubMed ID: 7066019)
1. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
Nelson TJ; Boor PJ
Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
[TBL] [Abstract][Full Text] [Related]
2. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Ramos K; Grossman SL; Cox LR
Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
[TBL] [Abstract][Full Text] [Related]
3. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells.
Hysmith RM; Boor PJ
Toxicology; 1988 Oct; 51(2-3):133-45. PubMed ID: 3140421
[TBL] [Abstract][Full Text] [Related]
4. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart.
Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE
Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003
[TBL] [Abstract][Full Text] [Related]
5. Binding of [14C] allylamine to isolated mitochondria from rat heart and aorta.
Hysmith RM; Boor PJ
Toxicology; 1987 Apr; 44(1):13-29. PubMed ID: 3105119
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein.
Biagini RE; Toraason MA; Lynch DW; Winston GW
Toxicology; 1990 May; 62(1):95-106. PubMed ID: 2343460
[TBL] [Abstract][Full Text] [Related]
7. Three types of stereospecificity and the kinetic deuterium isotope effect in the oxidative deamination of dopamine as catalyzed by different amine oxidases.
Yu PH
Biochem Cell Biol; 1988 Aug; 66(8):853-61. PubMed ID: 3143375
[TBL] [Abstract][Full Text] [Related]
8. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
Conklin DJ; Langford SD; Boor PJ
Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
[TBL] [Abstract][Full Text] [Related]
9. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
[TBL] [Abstract][Full Text] [Related]
10. A role for a new vascular enzyme in the metabolism of xenobiotic amines.
Boor PJ; Hysmith RM; Sanduja R
Circ Res; 1990 Jan; 66(1):249-52. PubMed ID: 2104785
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of the cardiovascular toxin, allylamine, by rat and human cardiovascular tissue.
Boor PJ; Nelson TJ
J Mol Cell Cardiol; 1982 Nov; 14(11):679-82. PubMed ID: 7154100
[No Abstract] [Full Text] [Related]
12. An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase.
Lyles GA; Fitzpatrick CM
J Pharm Pharmacol; 1985 May; 37(5):329-35. PubMed ID: 2862241
[TBL] [Abstract][Full Text] [Related]
13. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
Pino R; Lyles GA
Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
[TBL] [Abstract][Full Text] [Related]
14. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
Boor PJ; Nelson TJ
Toxicology; 1980; 18(2):87-102. PubMed ID: 7256782
[No Abstract] [Full Text] [Related]
15. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
Conklin DJ; Trent MB; Boor PJ
Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
[TBL] [Abstract][Full Text] [Related]
16. Possible different fates for the hydrogen peroxide produced by rat white adipocyte amine oxidases.
Raimondi L; Banchelli G; Sgromo L; Pirisino R
Neurobiology (Bp); 2000; 8(1):99-107. PubMed ID: 11008881
[TBL] [Abstract][Full Text] [Related]
17. Monoamine and diamine oxidative deamination in the longitudinal smooth muscle of guinea pig ileum.
Banchelli G; Raimondi L; Ignesti G; Pirisino R; Buffoni F
Med Biol; 1985; 63(1):34-9. PubMed ID: 3999819
[TBL] [Abstract][Full Text] [Related]
18. In vivo metabolism of the cardiovascular toxin, allylamine.
Boor PJ; Sanduja R; Nelson TJ; Ansari GA
Biochem Pharmacol; 1987 Dec; 36(24):4347-53. PubMed ID: 3689456
[TBL] [Abstract][Full Text] [Related]
19. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
Awasthi S; Boor PJ
Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in benzylamine oxidase activity in rat tissues.
Cao Danh H; Strolin Benedetti M; Dostert P; Mousset A
J Pharm Pharmacol; 1984 Sep; 36(9):592-6. PubMed ID: 6149282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
